Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Hits New 12-Month High – Should You Buy?

Shares of Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) hit a new 52-week high on Friday . The company traded as high as $9.85 and last traded at $9.8340, with a volume of 3567 shares trading hands. The stock had previously closed at $9.53.

Shionogi & Co., Ltd. Unsponsored ADR Trading Up 4.4%

The company has a market cap of $16.93 billion, a PE ratio of 15.55, a P/E/G ratio of 2.07 and a beta of 0.19. The company has a current ratio of 6.44, a quick ratio of 5.74 and a debt-to-equity ratio of 0.01. The business’s 50-day simple moving average is $8.86 and its 200-day simple moving average is $8.67.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last issued its earnings results on Monday, October 27th. The company reported $0.18 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.02. Shionogi & Co., Ltd. Unsponsored ADR had a return on equity of 11.90% and a net margin of 39.53%.The company had revenue of $740.85 million for the quarter, compared to analyst estimates of $742.35 million. As a group, analysts expect that Shionogi & Co., Ltd. Unsponsored ADR will post 0.66 EPS for the current fiscal year.

Shionogi & Co., Ltd. Unsponsored ADR Company Profile

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.